-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

311.P1.50 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I

Symposia: Disorders of Platelet Number or Function: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Andres Ramirez Lopez1,2*, María Teresa Alvarez Román, MD, PhD1,3,4*, María Isabel Rivas Pollmar, MD, PhD1,3*, Mónica Martín Salces, MD, PhD1,3*, Mar Gutierrez, MD1,3*, Eduardo Garcia Perez, MD1,3*, Elena G Arias-Salgado, PhD1,3*, Elena Monzón Manzano, PhD1,3*, Paula Acuña, BSc1,3*, Víctor Jiménez Yuste, MD, PhD1,3,4*, Nora V. Butta, PhD3,5* and Cédric Hermans, MD, MRCP, PhD6

1Hospital Universitario La Paz, Madrid, Spain
2Hospital General La Mancha Centro, Alcazar de San Juan, Spain
3IdiPAZ, Madrid, Spain
4Universidad Autónoma de Madrid, Madrid, Spain
5Hospital Universitario La Paz, Madrid, Madrid, Spain
6Division of Hematology, Cliniques Univ. Saint-Luc, Brussels, Belgium

Vickie McDonald1*, Charlotte Bradbury, MD2*, Kate Talks, MD3*, Gillian Lowe, MA MB BChir, MRCP, FRCPath, PhD4*, Sue Pavord, MD5*, Gillian Evans, MD6*, Manoharan Andiappan, PhD7*, Darcie Sandschafer, PhD8*, Vitor Jose De Sousa Barbosa, PhD9*, Lorraine Stephens, BSc Hon10* and Nichola Cooper, MD11

1Royal London Hospital, Barts Health NHS Trust, London, ENG, United Kingdom
2Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
3Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom
4Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
5Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
6Kent and Canterbury Hospital, East Kent University Hospitals Foundation Trust, Canterbury, United Kingdom
7Open Health, Marlow, United Kingdom
8Amgen Inc, Thousand Oaks, CA
9Amgen Inc., Thousand Oaks, CA
10Amgen Ltd, Cambridge, United Kingdom
11Centre For Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

Eyal Elron, MD1*, Osama Tanous, MD2*, Esti Shamba, MSc3*, Orna Steinberg Shemer, MD3, Tracie Goldberg, MD4*, Shai Izraeli, MD5,6, Joanne Yacobovich, MD3* and Oded Gilad, MD7,8*

1Department of Neonatology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Petach Tikva, Israel
2Clalit health services, Israel, Tel Aviv, Israel
3Department of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel, affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Petach Tikva, Israel
4Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel
5Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
6Department of Pediatric Hematology Oncology, Schneider Children Medical Center of Israel, Petach Tikva, Israel
7Schneider Children's Medical Center of Israel, Schneider Children Medical Center of Israel, Petach Tikva, Israel
8Sackler faculty of Medicine, Tel Aviv university, Israel, Tel Avivi, Israel

Oliver Meyer, MD1*, Rudolf Schlag2*, Thomas Stauch3*, Bastian Fleischmann4*, Marcel Reiser5*, Dietrich Kaempfe6, Timo Behlendorf7*, Manfred Welslau8*, Eyck von der Heyde9*, Steffen Dörfel10*, Claudia Willy11* and Martina Stauch12*

1Blutspendedienst der Landesverbände des DRK in Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH, Springe, Germany
2Practice for Hematology and Oncology, Würzburg, Germany
3MEDIAN Rehabilitation Center, Bad Berka, Germany
4Center for Oncology, , Germany, Donauwörth, Germany
5PIOH Center, Cologne, Germany
6Practice for Hematology and Oncology, Luedenscheid, Germany
7Practice for Hematology and Oncology, Halle (Saale), Germany
8Practice for Hematology and Oncology, Medical Center Aschaffenburg, Aschaffenburg, Germany
9Practice for Oncology, Hannover, Germany
10Onkozentrum Dresden, Dresden, Germany
11Novartis Pharma GmbH, Nuremberg, Germany
12Outpatient Center for Hematology Oncology and Haemostasis, Kronach, Germany

Silvana Novelli, MD, PhD1, Carlos Zamora2*, Silvia Vidal2*, David Valcarcel, MD, PhD3, Blanca Sanchez-Gonzalez, MD4*, Francesc Garcia-Pallarols, BSc5*, Yva Rodriguez, MD6*, Abel Domingo7*, Marta Canet Maldonado8* and Pável E Olivera, MD9*

1Department of Hematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
2INSTITUT DE RECERCA, HOSPITAL DE LA SANTA CREU I SANT PAU, Barcelona, Spain
3Department of Hematology, Vall d’Hebron University Hospital. Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
4Hematology Department, Hospital del Mar, Barcelona, Spain
5Group of Applied Clinical Research in Hematology, IMIM-Hospital del Mar, Barcelona, Spain
6Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
7Hospital Universitari de Granollers, Granollers, Spain
8Hospital Mutua Terrassa, Terrassa, Spain
9Banc de Sang i Teixits, Unit of antithrombotic therapy, Barcelona, Spain

Andrew Laws1*, David Gomez-Ulloa2*, Eva Calvo2*, Duncan Stacey3*, Jean Hamilton4* and Vickie McDonald5*

1FIECON, London, United Kingdom
2Grifols, Sant Cugat Del Vallès, Spain
3Grifols UK Ltd, Cambridge, United Kingdom
4School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom
5Royal London Hospital, Barts Health NHS Trust, London, ENG, United Kingdom

Min Xu1*, Lin lin Huang2*, Yu Hu, MD3,4* and Heng Mei4*

1Institute of hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Institute of Haematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, AL, CHN
3Hubei clinical medical center of cell therapy for neoplastic disease, Wuhan, China
4Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Rocel C. Saputil, MSc1*, Joanne L. Dunster, PhD2*, Neline Kriek, PhD2*, Yunchuan Ding, PhD1*, Anuradha Bhide, MBBS, MRes, MRCP1,3*, Alice C J Hart, MBBS, BSc, MRCP, FRCPath1,3*, Michelle MH Tan, MSc1*, Emma Thorley, MB BChir, BA3*, Ariam Teklemichael, BSc3*, Wayne A. Mitchell, PhD4*, Amna Malik, PhD1*, Jonathan M. Gibbins, BSc, PhD2 and Nichola Cooper, MD1,3

1Centre For Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
2Institute for Cardiovascular and Metabolic Research, School of BIological Sciences, University of Reading, Reading, United Kingdom
3Imperial College Healthcare NHS Trust, London, United Kingdom
4Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

Nicholas C.J. Lee, MD1, Sean Yates, MD2, Siayareh Rambally, MD3, Ravindra Sarode, MD4, Ibrahim F. Ibrahim, MD3, Yu-Min Shen, MD3, Sandra L. Hofmann, MD, PhD3 and Natalie Bavli, MD3*

1Departments of Internal Medicine and Pediatrics, University of Texas Southwestern, Dallas, TX
2Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX
3Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
4Division of Transfusion Medicine and Hemostasis, Department of Pathology and Internal Medicine (Hematology/Oncology), UT Southwestern Medical Center, Dallas, TX

Maria Luisa Lozano, MD, PhD1*, Ana Zamora-Cánovas, MSc2*, Belen De La Morena-Barrio, PhD2*, Cristina Sierra, MD3*, Christoph Male, MD4*, Jose Padilla2*, Maria Eugenia de la Morena-Barrio, PhD2, Veronica Palma-Barqueros, PhD2*, Ana Sánchez-Fuentes, MSc, MD2*, Agustín Rodriguez-Alen, MD, PhD5*, Ana Marín-Quílez, MSc6*, Nuria Revilla Calvo, MD, PhD7*, Vicente Vicente, MD, PhD2*, Jose Maria Bastida, MD, PhD6,8*, Javier Corral, PhD2* and Jose Rivera Pozo, PhD2,8*

1Servicio de Hematología y Oncología Médica. H.U. Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB-Arrixaca, Murcia, Spain
2Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER-U765, Murcia, Spain
3Servicio de Hematología, Hospital Universitario Cruces, Baracaldo, Bilbao, Spain
4Department of Paediatrics, Medical University of Vienna, Vienna, Austria
5Servicio de Hematología y Hemoterapia, Hospital Virgen de la Salud, Toledo, Spain
6Departmento de Hematología, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca (USAL), Salamanca, Spain
7Department of Hematology, Hospital Universitario Fundación Jiménez Díaz, Instituto Investigación Sanitaria FJD (IIS-FJD), Madrid, Spain
8On behalf of Grupo Español de Alteraciones Plaquetarias Congénitas (GEAPC), Madrid, Spain

Steven Roy, MD1*, Audrey Ann Labrecque, MD2*, Antoine Dufour3*, Laurent Brechenmacher4*, Daniel Young5*, Si An Chen5*, Doan Le, MD6*, Stephanie Cooper, MD7*, Paul Gibson, MD8*, Ann E. Clarke, MD8* and Leslie Skeith, MD8

1Department of Critical Care Medicine, University of Calgary, Calgary, AB, Canada
2Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Montreal, Montreal, QC, Canada
3Departments of Physiology and Pharmacology, Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada
4Southern Alberta Mass Spectrometry Core Facility, University of Calgary, Calgary, AB, Canada
5University of Calgary, Calgary, AB, Canada
6Department of Pediatrics, University of Calgary, Calgary, AB, Canada
7Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB, Canada
8Department of Medicine, University of Calgary, Calgary, AB, Canada

Jennifer MacWhirter - DiRaimo1*, Caroline Kruse1*, Alexandra Kruse, MD1,2* and James B. Bussel, MD3

1Platelet Disorder Support Association, Cleveland, OH
2Tulane University School of Medicine, New Orleans, LA
3Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY

*signifies non-member of ASH